Yalamarty S, Filipczak N, Pathrikar T, Cotter C, Ataide J, Luther E
Drug Deliv Transl Res. 2024; 14(8):2171-2185.
PMID: 38507033
PMC: 11208241.
DOI: 10.1007/s13346-024-01562-5.
Yalamarty S, Filipczak N, Pathrikar T, Cotter C, Ataide J, Luther E
Res Sq. 2024; .
PMID: 38168301
PMC: 10760232.
DOI: 10.21203/rs.3.rs-3713164/v1.
Yalamarty S, Filipczak N, Li X, Pathrikar T, Cotter C, Torchilin V
Pharmaceutics. 2022; 14(7).
PMID: 35890364
PMC: 9324017.
DOI: 10.3390/pharmaceutics14071470.
Narayanaswamy R, Torchilin V
Pharm Res. 2021; 38(3):429-450.
PMID: 33655395
DOI: 10.1007/s11095-021-02986-1.
Mendes L, Rostamizadeh K, Gollomp K, Myerson J, Marcos-Contreras O, Zamora M
MAbs. 2020; 12(1):1850394.
PMID: 33323006
PMC: 7755171.
DOI: 10.1080/19420862.2020.1850394.
In vivo histone H1 migration from necrotic to viable tissue.
Luhrs K, Pink D, Schulte W, Zijlstra A, Lewis J, Parseghian M
Oncotarget. 2017; 8(10):16275-16292.
PMID: 28187445
PMC: 5369962.
DOI: 10.18632/oncotarget.15181.
NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.
Barry J, Vertegel A
Nano Life. 2014; 3(4).
PMID: 25414730
PMC: 4235794.
DOI: 10.1142/S1793984413430010.
On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles.
Lukianova-Hleb E, Ren X, Sawant R, Wu X, Torchilin V, Lapotko D
Nat Med. 2014; 20(7):778-784.
PMID: 24880615
PMC: 4271542.
DOI: 10.1038/nm.3484.
Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
Perche F, Patel N, Torchilin V
J Control Release. 2012; 164(1):95-102.
PMID: 22974689
PMC: 3502646.
DOI: 10.1016/j.jconrel.2012.09.003.
Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
Biswas S, Dodwadkar N, Sawant R, Torchilin V
Bioconjug Chem. 2011; 22(10):2005-13.
PMID: 21870873
PMC: 3197796.
DOI: 10.1021/bc2002133.
Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.
Elbayoumi T, Torchilin V
Clin Cancer Res. 2009; 15(6):1973-80.
PMID: 19276264
PMC: 2762655.
DOI: 10.1158/1078-0432.CCR-08-2392.
Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.
Elbayoumi T, Torchilin V
Mol Pharm. 2008; 6(1):246-54.
PMID: 19049322
PMC: 2651224.
DOI: 10.1021/mp8001528.
Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice.
Elbayoumi T, Torchilin V
Int J Pharm. 2008; 357(1-2):272-9.
PMID: 18329201
PMC: 2680692.
DOI: 10.1016/j.ijpharm.2008.01.041.
Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.
Elbayoumi T, Torchilin V
Eur J Pharm Sci. 2007; 32(3):159-68.
PMID: 17707615
PMC: 2151083.
DOI: 10.1016/j.ejps.2007.05.113.
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
Gupta B, Torchilin V
Cancer Immunol Immunother. 2007; 56(8):1215-23.
PMID: 17219149
PMC: 11030931.
DOI: 10.1007/s00262-006-0273-0.
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.
Elbayoumi T, Torchilin V
Eur J Nucl Med Mol Imaging. 2006; 33(10):1196-205.
PMID: 16763815
DOI: 10.1007/s00259-006-0139-x.
Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.
Roby A, Erdogan S, Torchilin V
Eur J Pharm Biopharm. 2005; 62(3):235-40.
PMID: 16326084
PMC: 1634738.
DOI: 10.1016/j.ejpb.2005.09.010.
Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.
Torchilin V, Lukyanov A, Gao Z, Papahadjopoulos-Sternberg B
Proc Natl Acad Sci U S A. 2003; 100(10):6039-44.
PMID: 12716967
PMC: 156322.
DOI: 10.1073/pnas.0931428100.
